MXCT MaxCyte Inc Year-over-year net earnings per share growth for the last 12 months

maxcyte.com - graphic logo of issuer MXCT

MaxCyte, Inc. (MXCT) generates revenue by supplying electroporation systems to the biotech sector and pharmaceutical companies. High switching costs to alternative solutions guarantee the brand's pricing power over consumables. An impeccable reputation in cell engineering ensures the trust of major corporations. Analysis of quarterly EPS growth reflects fundamental momentum, where the value settled at 28.20, signaling the current state of profitability.

maxcyte.com (MXCT) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/10/2026

Comprehensive metric breakdowns and analytics for MaxCyte Inc (MXCT)

- share price and expert price forecast:
Stock Price MaxCyte|MXCT - Consensus Target
- market capitalization data:
Market Valuation MaxCyte, Inc|MXCT - Value Adjusted for Debt and Cash
- book capitalization indicators:
Net Assets per Single Share MaxCyte|MXCT - Company Net Assets|Market Capitalization to Book Value Ratio maxcyte.com|MXCT - Company Assets
- business debt structure and liquidity details:
Total Debt to Capital MaxCyte, Inc.|MXCT - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital MaxCyte, Inc.|MXCT - Company Total Debt Obligations|Debts to Book Capitalization MaxCyte, Inc|MXCT - Company Long-Term Liabilities|Company Short-Term Debts MaxCyte|Quick Liquidity maxcyte.com
- earnings and market multiples details:
MXCT - Company Net Income|Future Profit MaxCyte, Inc.|MXCT - Company Value to Net Income|Forward P/E Multiple MaxCyte, Inc|MXCT - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MaxCyte, Inc|MXCT - Operating profit before depreciation charges|Net earnings per share for the last 12 months MaxCyte|MXCT - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth maxcyte.com|MXCT - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year MaxCyte, Inc.
Analysis of all company metrics:MaxCyte - MXCT
Flagship merchandise of MaxCyte Inc

MaxCyte, Inc. (MXCT) is developing a unique B2B ecosystem where the integration of its technologies into clients' FDA filings ensures exceptional customer loyalty. The relative change in quarterly EPS reflects the dynamics of net income per share compared to the previous period. This metric measures the pace of capital scaling and reacts sensitively to operational efficiency. The positive trend confirms the monetization of customer lock-in, rendering the asset fundamentally resilient.

Main competitors

ABT: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Thermo Fisher Scientific Inc.|Year-over-year net earnings per share growth for the last 12 months GEHC|MTD: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Waters Corporation (WAT)|Year-over-year net earnings per share growth for the last 12 months bio-techne.com TECH|Quarterly EPS earnings growth BRKR (Bruker)|Azenta Inc (AZTA) - Earnings per share growth in annualized terms for the last twelve months|Varex - Quarterly EPS earnings growth|SMLR (Semler) - Year-over-year earnings per share growth for the last 12 months|BFLY: Quarterly EPS earnings growth|MLAB - Year-over-year net earnings per share change for the last twelve months|QSI (Quantum-Si Incorporated) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Nano-X Imaging (NNOX)|Quarterly EPS earnings growth QTRX|Quarterly EPS earnings growth 908 Devices Corporation (MASS)|Year-over-year earnings per share growth for the last twelve months CapsoVision CV|Rapid Micro Biosystems Inc. - Year-over-year earnings per share growth for the last twelve months|SEER: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months HYPR (Hyperfine Inc)|FONR: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Daxor (DXR)|Year-over-year earnings per share growth for the last twelve months Spectral AI, Inc.|VIVS - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months ACON (Aclarion, Inc.)|Quarterly EPS earnings growth akoyabio.com (AKYA)|Quarterly EPS earnings growth THMO (ThermoGenesis Holdings Inc.)|Year-over-year net earnings per share change for the last twelve months Talis Biomedical Corp. (TLIS)|TTOO - Year-over-year earnings per share growth for the last twelve months